Mutations in SDHC cause autosomal dominant paraganglioma, type 3
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Nonchromaffin paragangliomas (PGLs) are usually benign, neural-crest-derived, slow-growing tumours of parasympathetic ganglia. Between 10% and 50% of cases are familial and are transmitted as autosomal dominant traits with incomplete and age-dependent penetrance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [4]
In the citing paper
“In 2008, mutation of SDH was discovered in cancers such as paraganglioma and pheochromocytoma cells124. Later, similar observations were made in gastrointestinal tumors, neuroblastomas, renal tumors, thyroid tumors, and testicular tumors125,126.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [126]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
PROSPECTIVE RANDOMISED TRIAL OF EARLY DIETARY PROTEIN RESTRICTION IN CHRONIC RENAL FAILURE
Rosman, J., Ter Wee, P., Meijer Truus, S., Piers-Becht, P. M., Sluiter, W., & Donker, A. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90818-3 · Cited by 555
GENOMIC IMPRINTING IN HEREDITARY GLOMUS TUMOURS: EVIDENCE FOR NEW GENETIC THEORY
Van Der Mey, A. L., Maaswinkel-Mooy, P., Cornelisse, C., Schmidt, P., & Van De Kamp, J. P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91908-9 · Cited by 305
Familial carotid body tumors: Case report and epidemiologic review
Grufferman, S., Gillman, M. W., Pasternak, L. R., Peterson, C. L., & Young, W. G. (1980) · Cancer · doi:10.1002/1097-0142(19801101)46:9<2116::aid-cncr2820460934>3.0.co;2-s · Cited by 240
Heutink, P., Mey, A. G. L. V. D., Sandkuijl, L. A., Gils, A. P. G. V., Bardoel, A., Breedveld, G. J., Vliet, M. V., Ommen, G.-J. B. V., Cornelisse, C. J., Oostra, B. A., et al. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.1.7 · Cited by 214
Mariman, E. C. M., van Beersum, S. E. C., Cremers, C. W. R. J., Struycken, P., & Ropers, H. (1995) · Human Genetics · doi:10.1007/bf00225075 · Cited by 136
Hirawake, H., Taniwaki, M., Tamura, A., Kojima, S., & Kita, K. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134700 · Cited by 62
Repositioning the hereditary paraganglioma critical region on chromosome band 11q23
Baysal, B. E., van Schothorst, E. M., Farr, J. E., Grashoff, P., Myssiorek, D. J., Rubinstein, W. S., Taschner, P. E. M., Cornelisse, C. J., Devlin, B., Devilee, P., et al. (1999) · Human Genetics · doi:10.1007/s004390050939 · Cited by 58
PGL3 , a third, not maternally imprinted locus in autosomal dominant paraganglioma
Niemann, S., Steinberger, D., & Müller, U. (1999) · Neurogenetics · doi:10.1007/s100480050078 · Cited by 54
Self-citation
Cited by
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
“Familial paraganglioma can be caused by mutations in SDHB , SDHC , or SDHD , three of the four SDH sub-units (Astuti et al., 2001; Baysal et al., 2000; Niemann and Muller, 2000).”
BackgroundWallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
“Mutations in the mitochondrial fumarate hydratase have been associated with uterine leiomyomas and renal cell carcinomas (112), and mutations in three of the four nDNA-encoded subunits of complex II have been linked to paragangliomas: SDHD (cytb membrane subunit) (15), SDHC (coenzyme Q-binding membrane subunit) (162),…”
BackgroundPheochromocytoma and paraganglioma: an endocrine society clinical practice guideline
Lenders, J. W. M., Duh, Q.-Y., Eisenhofer, G., Gimenez-Roqueplo, A.-P., Grebe, S. K. G., Murad, M. H., Naruse, M., Pacak, K., & Young, W. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1498 · Cited by 2,827
“No. of Cases Mutations SDHB SDHD SDHC VHL RET NF1 SDHA SDHAF2 TMEM127 MAX n % Lefebvre, 2012 (170) 269 21 12 6 ND ND ND ND 0 5 ND 44 16.3 Amar, 2005 (165); Burnichon, 2009 (166) 721 99 131 16 25 16 13 ND ND ND ND 300 41.6 Mannelli, 2009 (162) 501 24 47 4 48 27 11 ND ND ND ND 161 32.1 Cascón, 2009 (163) 237 25 11 1 20…”
InfluentialMitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,661
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
“…herein: PGL1 (MIM 168000), which results from SDHD mutations at 11q23; PGL2 (MIM 601650), which maps to 11q13, although the causative gene has not been identified (Mariman et al. 1995); and PGL3 (MIM 605373), which results from SDHC mutations at 1q21 (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundInfluentialGlutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
“Inherited neoplastic syndromes are also associated with mutation of the succinate dehydrogenase (SDH) complex (Astuti et al., 2001; Baysal et al., 2000; Niemann and Muller, 2000), which catalyzes the conversion of succinate to fumarate in the TCA cycle.”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893
“Multifocal tumors 9 28 (14-47) 25 74 (56-87) .”
Butow, R. A., & Avadhani, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00179-0 · Cited by 882
Crystal Structure of Mitochondrial Respiratory Membrane Protein Complex II
Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., & Rao, Z. (2005) · Cell · doi:10.1016/j.cell.2005.05.025 · Cited by 881
“…respiratory system and are mainly associated with mutation or truncastion of Complex II (Ackrell, 2002; Astuti et al., 2001a; Astuti et al., 2001b; Baysal et al., 2000; Bourgeron et t Cal., 1995; Douwes Dekker et al., 2003; Ishii et al., 1998; Niemann and Muller, 2000; Rustin and Rotig, 2002).”
BackgroundPollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
“SDHC mutations appear to be uncommon (4).”
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
Mitochondrial mutations in cancer
Brandon, M., Baldi, P., & Wallace, D. C. (2006) · Oncogene · doi:10.1038/sj.onc.1209607 · Cited by 818
“The linkage of mutations in nDNA-encoded mitochondrial gene mutations to cancer (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001; Lehtonen et al., 2004; Vanharanta et al., 2004) raises the possibility that mtDNA mutations might also contribute to cancer etiology.”
BackgroundPheochromocytoma and Paraganglioma
Neumann, H. P. H., Young, W. F., & Eng, C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806651 · Cited by 736
The genetics and pathology of oxidative phosphorylation
Smeitink, J., van den Heuvel, L., & DiMauro, S. (2001) · Nature Reviews Genetics · doi:10.1038/35072063 · Cited by 724
Genetic Testing in Pheochromocytoma or Functional Paraganglioma
Amar, L., Bertherat, J., Baudin, E., Ajzenberg, C., Bressac-de Paillerets, B., Chabre, O., Chamontin, B., Delemer, B., Giraud, S., Murat, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.1484 · Cited by 684
Kurhanewicz, J., Vigneron, D. B., Brindle, K., Chekmenev, E. Y., Comment, A., Cunningham, C. H., DeBerardinis, R. J., Green, G. G., Leach, M. O., Rajan, S. S., et al. (2011) · Neoplasia · doi:10.1593/neo.101102 · Cited by 681
“Similarly, mutations in the TCA cycle enzyme fumarate hydratase occur in a familial form of leiomyomatosis and renal cell cancer [13,22,23].”
BackgroundSuccinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
“Following this initial discovery, it did not take long to identify the genes of two other HPGL-associated loci, PGL4 (1p36) and PGL3 (1q21), to be SDHB and SDHC, respectively (Niemann and Muller, 2000; Astuti et al., 2001).”
BackgroundJaneway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
Realizing the promise of cancer predisposition genes
Rahman, N. (2014) · Nature · doi:10.1038/nature12981 · Cited by 624
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1737 · Cited by 621
Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaître, X. (2003) · PubMed · Cited by 609
Function and Structure of Complex II of the Respiratory Chain
Cecchini, G. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161700 · Cited by 556
The emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2018) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 556
“Mutations in SDHA, SDHB, SDHC, SDHD and SDH assembly factor 2 (SDHAF2) have been identified in hereditary paragangliomas (hPGLs) and pheochromocytomas (PCCs) (Table 1) (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001; Baysal et al., 2002; Hao et al., 2009; Bayley et al., 2010; Burnichon et al., 2010…”
BackgroundPheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patocs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 539
Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma?
Jose, C., Bellance, N., & Rossignol, R. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.012 · Cited by 518
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
Favier, J., Amar, L., & Gimenez-Roqueplo, A.-P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.188 · Cited by 490
Genome-wide analysis of noncoding regulatory mutations in cancer
Weinhold, N., Jacobsen, A., Schultz, N., Sander, C., & Lee, W. (2014) · Nature Genetics · doi:10.1038/ng.3101 · Cited by 484
“CLL (28) Colon (16) Rectum (9) Glioblastoma (25) Head and neck (29) Kidney chromophobe (15) Kidney clear cell (29) Low-grade glioma (18) Liver (88) Lung adenocarcinoma (24) Lung adenocarcinoma (40) Lung squamous (20) Lymphoma (24) Medulloblastoma (100) Ovary (5) Pancreas (15) Prostate (20) Melanoma (17) Thyroid (9) Ut…”
BackgroundMoonlighting proteins: old proteins learning new tricks
Jeffery, C. J. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00167-7 · Cited by 479
Succinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
“These four FPS clinical entities each now have been associated with germline mutations in succinate dehydrogenase (SDH) genes: SDHD (PGL1), SDH5 (PGL2), SDHC (PGL3), and SDHB (PGL4).”
BackgroundInfluentialMitochondrial dysfunction and mitochondrial dynamics-The cancer connection
Srinivasan, S., Guha, M., Kashina, A., & Avadhani, N. G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.004 · Cited by 436
Ayala-Ramirez, M., Feng, L., Johnson, M. M., Ejaz, S., Habra, M. A., Rich, T., Busaidy, N., Cote, G. J., Perrier, N., Phan, A., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1946 · Cited by 428
“Overall 267 (72%) 104 (28%) 371 (100%) Age (yr) 41 (6-83) 41 (5-77) 0.”
National Cancer Data Base report on malignant paragangliomas of the head and neck
Lee, J. H., Barich, F., Karnell, L. H., Robinson, R. A., Zhen, W. K., Gantz, B. J., Hoffman, H. T., & American College of Surgeons Commission on Cancer and the American Cancer Society (2002) · Cancer · doi:10.1002/cncr.10252 · Cited by 427
“to a paraganglioma in the familial form recently was characterized.(9) Multicentric tumors (i.”
BackgroundCancer cell metabolism: implications for therapeutic targets
Jang, M., Kim, S. S., & Lee, J. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.85 · Cited by 397
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
A role for mitochondrial enzymes in inherited neoplasia and beyond
Eng, C., Kiuru, M., Fernandez, M. J., & Aaltonen, L. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1013 · Cited by 392
Burnichon, N., Rohmer, V., Amar, L., Herman, P., Leboulleux, S., Darrouzet, V., Niccoli, P., Gaillard, D., Chabrier, G., Chabolle, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2504 · Cited by 378
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
“The SDHC gene encoding the large subunit of cytochrome b in succinate-ubiquinone oxidoreductase was reported to correspond to the PGL3 gene (Niemann and Müller 2000; Niemann et al. 2001).”
BackgroundThe Significance of Mitochondrial Dysfunction in Cancer
Luo, Y., Ma, J., & Lu, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165598 · Cited by 362
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triad
Carney, J. A., & Stratakis, C. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10235 · Cited by 350
Germline SDHB Mutations and Familial Renal Cell Carcinoma
Ricketts, C., Woodward, E. R., Killick, P., Morris, M. R., Astuti, D., Latif, F., & Maher, E. R. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn254 · Cited by 342
Timmers, H. J. L. M., Kozupa, A., Chen, C. C., Carrasquillo, J. A., Ling, A., Eisenhofer, G., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6297 · Cited by 340
Baysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 339
Mullen, A. R., Hu, Z., Shi, X., Jiang, L., Boroughs, L. K., Kovacs, Z., Boriack, R., Rakheja, D., Sullivan, L. B., Linehan, W. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.037 · Cited by 337
Ricketts, C. J., Forman, J. R., Rattenberry, E., Bradshaw, N., Lalloo, F., Izatt, L., Cole, T. R., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21136 · Cited by 337
“Germline mutations in SDHC (MIM# 602413) may also cause inherited HNPGL and, rarely, pheochromocytoma [Niemann and Muller, 2000; Schiavi et al., 2005; Mannelli et al., 2007] but are much less frequent than SDHB and SDHD mutations.”
BackgroundMAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Burnichon, N., Cascón, A., Schiavi, F., Morales, N. P., Comino-Méndez, I., Abermil, N., Inglada-Pérez, L., de Cubas, A. A., Amar, L., Barontini, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0160 · Cited by 331
“The 10 percent rule was challenged after identification of germline mutations in SDHD, SDHB, and SDHC as important causes of familial paraganglioma (PGL)(4-6) that led Neumann and colleagues to establish that up to a quarter of affected patients carried a PCC/PGL”
BackgroundSchiavi, F. (2005) · JAMA · doi:10.1001/jama.294.16.2057 · Cited by 329
“Of interest, we could not find demographic, clinical, or pathological features that clearly differentiate between sporadic and SDHCassociated HNPs. Importantly, 4 of 5 indexcases (allwith jugular tumors)carrying an SDHC mutation had an outcome dominated by permanent palsy of at least 1 cranial nerve.”
BackgroundMethodInfluentialMetabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
Sciacovelli, M., & Frezza, C. (2017) · The FEBS Journal · doi:10.1111/febs.14090 · Cited by 329
Plathow, C., & Weber, W. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045930 · Cited by 328
“Mutations of succinate dehydrogenase (SDH) and fumarate hydratase (FH) gene are associated with the development of pheochromocytomas, leiomyomas, leiomyosarcoma, and renal cell carcinoma (8,29,30).”
BackgroundNew Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
A neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 316
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Burnichon, N., Vescovo, L., Amar, L., Libé, R., de Reynies, A., Venisse, A., Jouanno, E., Laurendeau, I., Parfait, B., Bertherat, J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr324 · Cited by 309
Huang, L.-S., Sun, G., Cobessi, D., Wang, A. C., Shen, J. T., Tung, E. Y., Anderson, V. E., & Berry, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511270200 · Cited by 308
Role of mitochondrial dysfunction in cancer progression
Hsu, C.-C., Tseng, L.-M., & Lee, H.-C. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216641787 · Cited by 305
Mitochondrial disorders of the OXPHOS system
Fernandez‐Vizarra, E., & Zeviani, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.13995 · Cited by 305
Mannelli, M., Castellano, M., Schiavi, F., Filetti, S., Giacchè, M., Mori, L., Pignataro, V., Bernini, G., Giachè, V., Bacca, A., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2419 · Cited by 303
“” More recent work has highlighted the importance of SDHB, SDHC, and SDHD genes that encode the B, C, and D subunits of succinate dehydrogenase (SDH), also known as mitochondrial complex II (3, 4, 5).”
Dong, L.-F., Low, P., Dyason, J. C., Wang, X.-F., Prochazka, L., Witting, P. K., Freeman, R., Swettenham, E., Valis, K., Liu, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.69 · Cited by 297
“Interestingly, several human cancers, such as paragangliomas, resulting from genetic disorders due to mutations in CII subunits, including SDHC, may also be induced by increased ROS formation (Niemann and Muller, 2000; Gottlieb and Tomlinson, 2005; Ishii et al., 2005).”
Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis
Cardaci, S., Zheng, L., MacKay, G., van den Broek, N. J. F., MacKenzie, E. D., Nixon, C., Stevenson, D., Tumanov, S., Bulusu, V., Kamphorst, J. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3233 · Cited by 286
“…mutations in the human genes for any of the SDH subunits, or the SDH complex assembly factor (SDHAF2), are associated with susceptibility to develop neuroendrocrine neoplasms, gastrointestinal stromal tumours as well as renal cell carcinoma (RCC) 2 , 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 .”
Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J. Q., Manfredi, G., Oda, H., & Ohta, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2012 · Cited by 286
Mitochondria and Cancer: Warburg Addressed
WALLACE, D. C. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.035 · Cited by 285
Succinate dehydrogenase and fumarate reductase from Escherichia coli
Cecchini, G., Schröder, I., Gunsalus, R. P., & Maklashina, E. (2002) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(01)00238-9 · Cited by 283
Bardella, C., El‐Bahrawy, M., Frizzell, N., Adam, J., Ternette, N., Hatipoglu, E., Howarth, K., O'Flaherty, L., Roberts, I., Turner, G., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2932 · Cited by 281
Korpershoek, E., Favier, J., Gaal, J., Burnichon, N., van Gessel, B., Oudijk, L., Badoual, C., Gadessaud, N., Venisse, A., Bayley, J.-P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1043 · Cited by 277
Timmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M., Adams, K. T., Solis, D., Lenders, J. W. M., & Pacak, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 276
Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 273
“…(33/45 HNPGLs and 11/11 adrenal or extra-adrenal PHEOs [10, 31, 34, 35, 51, 70, 81, 122, 126, 130], 60% of SDHB -related tumours (15/25 adrenal or extra-adrenal PHEOs) [12, 66, 79, 80, 85, 95, 113, 129, 132] and in all 5 tumours studied from carriers of SDHC germline mutations [11, 56, 93, 113].”
Senoo-Matsuda, N., Yasuda, K., Tsuda, M., Ohkubo, T., Yoshimura, S., Nakazawa, H., Hartman, P. S., & Ishii, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104718200 · Cited by 271
Revisiting the TCA cycle: signaling to tumor formation
Raimundo, N., Baysal, B. E., & Shadel, G. S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.001 · Cited by 271
“Dominant mutations in the SDH subunits SDHB, SDHC and SDHD predispose carriers to carotid body paragangliomas and adrenal gland pheochromocytomas [5, 14-16].”
BackgroundSuccinate dehydrogenase and human diseases: new insights into a well-known enzyme
Rustin, P., Munnich, A., & Rötig, A. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200793 · Cited by 257
Miyadera, H., Shiomi, K., Ui, H., Yamaguchi, Y., Masuma, R., Tomoda, H., Miyoshi, H., Osanai, A., Kita, K., & Ōmura, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237315100 · Cited by 256
Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P. S., & Ishii, N. (2005) · Cancer Research · doi:10.1158/0008-5472.203.65.1 · Cited by 253
“, paragangliomas) in humans (15), but the mechanism by which these mutation cause cancer is still unknown.”
Pheochromocytoma: The expanding genetic differential diagnosis.
Bryant, J., Farmer, J., Kessler, L. J., Townsend, R. R., & Nathanson, K. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg024 · Cited by 250
Andrews, K. A., Ascher, D. B., Pires, D. E. V., Barnes, D. R., Vialard, L., Casey, R. T., Bradshaw, N., Adlard, J., Aylwin, S., Brennan, P., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105127 · Cited by 248
Ghezzi, D., Goffrini, P., Uziel, G., Horvath, R., Klopstock, T., Lochmüller, H., D'Adamo, P., Gasparini, P., Strom, T. M., Prokisch, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.378 · Cited by 246
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
“Several studies have linked mutations in different subunits of SDH to cancer (Baysal et al., 2000; Niemann & Muller, 2000; Astuti et al., 2001).”
BackgroundSuccinate Dehydrogenase Kidney Cancer: An Aggressive Example of the Warburg Effect in Cancer
Ricketts, C. J., Shuch, B., Vocke, C. D., Metwalli, A. R., Bratslavsky, G., Middelton, L., Yang, Y., Wei, M.-H., Pautler, S. E., Peterson, J., et al. (2012) · Journal of Urology · doi:10.1016/j.juro.2012.08.030 · Cited by 240
Clinical spectrum and diagnosis of mitochondrial disorders
Munnich, A., & Rustin, P. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1391 · Cited by 239
Fishbein, L., Merrill, S., Fraker, D. L., Cohen, D. L., & Nathanson, K. L. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2942-5 · Cited by 238
Hereditary paraganglioma targets diverse paraganglia: Table 1
Baysal, B. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.617 · Cited by 235
Cellular oxygen sensing need in CNS function: physiological and pathological implications
Acker, T., & Acker, H. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01075 · Cited by 231
“…in the autosomally encoded enzyme and enzyme subunits are associated with hereditary predispositions to various tumors including paraganglioma, pheochromocytoma, benign smooth muscle cell tumor and RCC (Tomlinson et al., 2002; Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001).”
BackgroundLussey-Lepoutre, C., Hollinshead, K. E. R., Ludwig, C., Menara, M., Morin, A., Castro-Vega, L.-J., Parker, S. J., Janin, M., Martinelli, C., Ottolenghi, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms9784 · Cited by 227
“However, in Sdhb KO cells, the relative contribution of the 13C-[4,5]-glutamate was reduced by about 50%, and replaced by 13C-[2,3]-glutamate, which represents incorporation of labelled OAA into the TCA cycle (Fig.”
Grasso, D., Zampieri, L. X., Capelôa, T., Van de Velde, J. A., & Sonveaux, P. (2020) · Cell Stress · doi:10.15698/cst2020.06.221 · Cited by 227
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Smolková, K., Plecitá-Hlavatá, L., Bellance, N., Benard, G., Rossignol, R., & Ježek, P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 223
Zdzisińska, B., Żurek, A., & Kandefer-Szerszeń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0406-x · Cited by 221
“…to the development of certain types of cancer, mainly paragangliomas (Astuti et al. 2001; Baysal et al. 2000, 2002; Burnichon et al. 2010; Niemann and Muller 2000), pheochromocytomas (Astuti et al. 2001), renal cell carcinoma (Ricketts et al. 2008; Vanharanta et al. 2004), T cell acute…”
BackgroundIs cancer a disease of abnormal cellular metabolism? New angles on an old idea
Deberardinis, R. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31818b0d9b · Cited by 219
Head and neck paragangliomas: clinical and molecular genetic classification
Offergeld, C., Brase, C., Yaremchuk, S., Mader, I., Rischke, H. C., Gläsker, S., Schmid, K. W., Wiech, T., Preuss, S. F., Suárez, C., et al. (2012) · Clinics · doi:10.6061/clinics/2012(sup01)05 · Cited by 218
“Median (range, in years) 23 (7-39) 40 (12–74) 45 (15–65) 46 (13–73) 42 (9–75) 34”
BackgroundOncometabolites in renal cancer
Yong, C., Stewart, G. D., & Frezza, C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0210-z · Cited by 217
Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209
Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment
Martucci, V. L., & Pacak, K. (2014) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2014.01.001 · Cited by 204
van Gisbergen, M. W., Voets, A. M., Starmans, M. H. W., de Coo, I. F. M., Yadak, R., Hoffmann, R. F., Boutros, P. C., Smeets, H. J. M., Dubois, L., & Lambin, P. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.01.001 · Cited by 203
“In 2 other studies investigating families with paragangliomas carrying mutations in SDHD [39] or SDHC [40] a causative role was found for these mutations and a tumor suppressor function for the genes was suggested [39,40].”
Ngeow, J., Mester, J., Rybicki, L. A., Ni, Y., Milas, M., & Eng, C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1616 · Cited by 202
“04 Papillary follicular variant 6 (17) 102 (19) 0.”
Pugh, C. W., & Ratcliffe, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 201
Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis
Bellancé, N. (2009) · Frontiers in bioscience · doi:10.2741/3509 · Cited by 201
“Mutations in succinate dehydrogenase (SDH) and fumarate hydratase (FH) of the Krebs cycle have been reported as associated with Paraganglioma (94) or pheochromocytoma (95).”
Background
Metadata
- Authors
- Niemann, S., & Müller, U.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Corresponding author
- Müller, Ulrich
- ORCID
- Müller, Ulrich
- Venue
- Nature Genetics
- Published
- 2000-11
- Volume
- 26
- Issue
- 3
- Pages
- 268-270
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1528834211
- Cited by
- 875
- References
- 9
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 18 · 2022: 14 · 2021: 24 · 2020: 24 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 36 · 2015: 44 · 2014: 59 · 2013: 49 · 2012: 72
- FWCI
- 32.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- SDHC, nonchromaffin paraganglioma, autosomal dominant inheritance, familial paraganglioma, neural crest tumors, parasympathetic ganglia, penetrance
- MeSH terms
- Chromosomes, Human, Pair 1, DNA Mutational Analysis, Female, Genes, Dominant, Humans, Male, Membrane Proteins, Mitochondria, Molecular Sequence Data, Multienzyme Complexes, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Succinate Dehydrogenase, Mutagenesis, Site-Directed, DNA, Complementary, Protein Subunits, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.